Mutations presented The point that, as discussed below, CLL therapy relies around the existence or absence of these mutations. The present consensus is that, other than clonal mutations, subclonal mutations that has a variant allelic frequency starting from 5 to 10% (and as a consequence below the brink of detection https://edsgerd086wfn3.life3dblog.com/profile